171 related articles for article (PubMed ID: 32632699)
1. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
2. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
Lipsett SC; Branda JA; Nigrovic LE
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
[TBL] [Abstract][Full Text] [Related]
5. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
[TBL] [Abstract][Full Text] [Related]
8. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
Molins CR; Delorey MJ; Sexton C; Schriefer ME
J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
Baarsma ME; Vrijlandt A; Ursinus J; Zaaijer HL; Jurriaans S; van Dam AP; Hovius JW
Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):387-393. PubMed ID: 34806121
[TBL] [Abstract][Full Text] [Related]
10. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
Sabin AP; Scholze BP; Lovrich SD; Callister SM
Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
[TBL] [Abstract][Full Text] [Related]
14. Two-Tier Lyme Disease Serology Test Results Can Vary According to the Specific First-Tier Test Used.
Maulden AB; Garro AC; Balamuth F; Levas MN; Bennett JE; Neville DN; Branda JA; Nigrovic LE
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):128-133. PubMed ID: 30793167
[TBL] [Abstract][Full Text] [Related]
15. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
[TBL] [Abstract][Full Text] [Related]
16. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
[TBL] [Abstract][Full Text] [Related]
19. Lyme Disease Diagnosis: Serology.
Schriefer ME
Clin Lab Med; 2015 Dec; 35(4):797-814. PubMed ID: 26593258
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.
Baarsma ME; van de Schoor FR; Gauw SA; Vrijmoeth HD; Ursinus J; Goudriaan N; Popa CD; Ter Hofstede HJ; Leeflang MM; Kremer K; van den Wijngaard CC; Kullberg BJ; Joosten LA; Hovius JW
Lancet Infect Dis; 2022 Sep; 22(9):1388-1396. PubMed ID: 35714662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
